Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

LTGOLatigo Biotherapeutics, Inc.

Nasdaq · CIK 0002056611
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts125

Identity from submissions API

NameLatigo Biotherapeutics, Inc.
CIK0002056611
TickersLTGO
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC2834 Pharmaceutical Preparations
EIN832625838
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone805-716-2927
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
1300 RANCHO CONEJO BLVD., SUITE 305
THOUSAND OAKS
CA
CA
Mailing address
1300 RANCHO CONEJO BLVD., SUITE 305
THOUSAND OAKS
CA
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

49 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-18 4 xslF345X06/form4-11182026_091144.xml 0002143741-26-000005 5688
2026-11-18 4 xslF345X06/form4-11182026_091112.xml 0001866171-26-000005 5646
2026-11-18 4 xslF345X06/form4-11182026_091151.xml 0001523672-26-000010 5606
2026-11-16 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001753037-26-000010 005-95872 261562021 34 20495
2026-11-13 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001140361-26-043775 005-95872 261553232 34 6841
2026-11-06 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-452089 005-95872 261533023 34 132566
2026-11-05 10-Q 10-Q 0001193125-26-448582 001-43436 261524786 34 11396679 1 1
2026-11-05 8-K 8-K 2.02,5.02,9.01 0001193125-26-448537 001-43436 261524717 34 433156 1 1
2026-10-29 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-120296 005-95872 261503164 34 64716
2026-09-03 10-Q 10-Q 0001193125-26-381969 001-43436 261358812 34 11258503 1 1
2026-09-03 8-K 8-K 2.02,9.01 0001193125-26-381912 001-43436 261358558 34 409927 1 1
2026-08-18 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-355798 005-95872 261292317 34 261109
2026-08-17 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0001104659-26-097980 005-95872 261288071 34 50238
2026-08-17 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001346824-26-000233 005-95872 261287547 34 18917
2026-08-13 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-003404 005-95872 261273130 34 11347
2026-08-12 4 xslF345X06/form4-08122026_080846.xml 0001231919-26-000869 25813
2026-08-12 4 4 0001193125-26-345826 12437
2026-08-12 3 3 0001193125-26-345811 6860
2026-08-11 4 OWNERSHIP DOCUMENT 0001104659-26-093633 42877
2026-08-10 4 OWNERSHIP DOCUMENT 0001104659-26-093580 45898
2026-08-10 4 xslF345X06/form4-08102026_080806.xml 0001523672-26-000007 5490
2026-08-10 4 xslF345X06/form4-08102026_080804.xml 0001581754-26-000006 33583
2026-08-10 4 xslF345X06/form4-08102026_080801.xml 0001184592-26-000005 32587
2026-08-10 S-8 S-8 0001193125-26-342582 333-298197 261259243 33 480415 1 1
2026-08-10 8-K 8-K 5.03,8.01,9.01 0001193125-26-342321 001-43436 261258277 34 187294 1 1
2026-08-07 424B4 424B4 0001193125-26-340329 333-297518 261254380 33 7537699
2026-08-06 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002566 333-297518 261251228 33 1730
2026-08-06 3 OWNERSHIP DOCUMENT 0001104659-26-092247 24199
2026-08-06 3 xslF345X06/form3-08072026_120845.xml 0001231919-26-000841 18651
2026-08-06 3 OWNERSHIP DOCUMENT 0001104659-26-092240 25529
2026-08-06 3 xslF345X06/form3-08072026_120811.xml 0002144246-26-000002 9622
2026-08-06 3 xslF345X06/form3-08072026_120835.xml 0001349376-26-000006 13669
2026-08-06 3 xslF345X06/form3-08072026_120822.xml 0001866171-26-000002 13801
2026-08-06 3 xslF345X06/form3-08072026_120831.xml 0001523672-26-000006 9579
2026-08-06 3 xslF345X06/form3-08072026_120814.xml 0001604019-26-000012 11093
2026-08-06 3 xslF345X06/form3-08072026_120830.xml 0002143741-26-000002 14650
2026-08-06 3 xslF345X06/form3-08072026_120820.xml 0001808296-26-000006 15990
2026-08-06 3 xslF345X06/form3-08072026_120818.xml 0001581754-26-000003 21041
2026-08-06 3 xslF345X06/form3-08072026_120816.xml 0001184592-26-000004 23768
2026-08-06 S-1MEF S-1MEF 0001193125-26-338412 333-298083 261250318 33 190249 1 1
2026-08-06 CERT LTGO_8A_Cert_2056611.pdf 0001354457-26-000763 001-43436 261249764 34 564212
2026-08-04 8-A12B 8-A12B 0001193125-26-333075 001-43436 261239962 34 14335
2026-08-04 S-1/A S-1/A 0001193125-26-331205 333-297518 261235194 33 7623328
2026-08-03 S-1/A S-1/A 0001193125-26-329431 333-297518 261230311 33 8986923 1 1
2026-07-17 S-1 S-1 0001193125-26-307306 333-297518 261182740 33 9491927 1 1
2026-06-05 DRS/A filename1.htm 0001193125-26-259845 377-09184 261070015 33 7551693
2026-05-18 DRS/A filename1.htm 0001193125-26-227442 377-09184 26990337 33 7527404
2026-03-27 DRS filename1.htm 0001193125-26-129261 377-09184 26808168 33 9269558
2025-02-13 D xslFormDX01/primary_doc.xml 06b 0002056611-25-000001 021-538236 25620935 33 11865

Latest XBRL company facts

One latest value per concept from companyfacts (125 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 66.30M 2026-11-02 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
ffd NetFeeAmt NetFeeAmt USD 18,140.14 2026-08-08 S-8 2026-08-10 0001193125-26-342582
ffd TtlFeeAmt TtlFeeAmt USD 18,140.14 2026-08-08 S-8 2026-08-10 0001193125-26-342582
ffd TtlOfferingAmt TtlOfferingAmt USD 131.35M 2026-08-08 S-8 2026-08-10 0001193125-26-342582
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-08-08 S-8 2026-08-10 0001193125-26-342582
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-08-06 S-1MEF 2026-08-06 0001193125-26-338412
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 5.08M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap AccruedBonusesCurrent Accrued Bonuses, Current USD 2.85M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap AccruedLiabilitiesAndOtherLiabilities Accrued Liabilities and Other Liabilities USD 8.17M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 294,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 1.01M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 706.80M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 2.54M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 6.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 975,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 10.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap Assets Assets USD 408.46M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap AssetsCurrent Assets, Current USD 406.44M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 401.24M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 401.41M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 331.69M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 14.23M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap CommonStockDividendsPerShareDeclared Common Stock, Dividends, Per Share, Declared USD/shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 1000.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 66.30M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 66.30M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap CommonStockValue Common Stock, Value, Issued USD 7,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 288.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap ConvertibleNotesPayable Convertible Notes Payable USD 35.00M 2026-06-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap ConvertibleNotesPayableCurrent Convertible Notes Payable, Current USD 30.66M 2026-08-10 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 35.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap DebtConversionConvertedInstrumentSharesIssued1 Debt Conversion, Converted Instrument, Shares Issued shares 1.96M 2026-08-10 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 35.00M 2026-08-10 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap DebtInstrumentConvertibleConversionPrice1 Debt Instrument, Convertible, Conversion Price USD/shares 18 2026-08-10 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 35.00M 2026-06-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.05 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap DebtInstrumentUnamortizedDiscountCurrent Debt Instrument, Unamortized Discount, Current USD 4.46M 2026-08-10 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap DeferredFinanceCostsCurrentNet Debt Issuance Costs, Current, Net USD 124,000 2026-08-10 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap DeferredFinanceCostsNet Debt Issuance Costs, Net USD 200,000 2026-06-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap Depreciation Depreciation USD 152,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap DerivativeGainLossOnDerivativeNet Derivative, Gain (Loss) on Derivative, Net USD 5.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 5.15M 2026-06-30 2026 Q2 10-Q 2026-09-03 0001193125-26-381969
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -5.22 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -5.22 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability Embedded Derivative, Fair Value of Embedded Derivative Liability USD 5.10M 2026-06-01 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet Embedded Derivative, Gain (Loss) on Embedded Derivative, Net USD 5.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 660,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 24.40M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD -4.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 15.81M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 70,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD -4.69M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap IncreaseDecreaseInDerivativeLiabilities Increase (Decrease) in Derivative Liabilities USD 0 2026-06-01 2026-06-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -461,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD -92,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 833,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap InterestAndOtherIncome Interest and Other Income USD 2.86M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 950,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap LesseeOperatingLeaseDiscountRate Lessee, Operating Lease, Discount Rate pure 0.126 2026-04-01 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap Liabilities Liabilities USD 14.48M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 408.46M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap LiabilitiesCurrent Liabilities, Current USD 13.96M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 399.71M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -146,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -67.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -69.71M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -69.71M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 2.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-09-03 0001193125-26-381969
us-gaap OperatingExpenses Operating Expenses USD 72.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -72.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 1.00M 2026-04-01 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 705,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 483,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 1.14M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 442,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 433,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 35,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -15,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 738,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 33.10M 2026-08-01 2026-08-31 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 146,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 5.03M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap PrepaidInsurance Prepaid Insurance USD 1.23M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 34.83M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 364.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock Proceeds from Issuance of Redeemable Convertible Preferred Stock USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 496,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 1.45M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 440,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 56.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 168,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -312.84M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 959,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 6.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 0.776 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 0.735 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.044 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.038 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 393.97M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 288.58M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 364.38M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 265,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 13.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap WeightedAverageNumberOfSharesIssuedBasic Weighted Average Number of Shares Issued, Basic shares 13.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 13.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448582

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →